Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Calvert FormulaDIPSS-Plus (Myelofibrosis)Deauville ScoreEAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2Fleischner 2017 GuidelinesFong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)ISUP Grade GroupsKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022MIPI-b (Biological)MRD Assessment FrameworkMSI/MMR InterpretationMayo 20/2/20 (SMM)NCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0PREDICT v3.0Platinum-Free IntervalR2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSINS ScoreSLiM-CRAB CriteriaSedlis/Peters CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 EligibilityiRECISTiwCLL 2018 ResponsemRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Fleischner 2017 Guidelines

FLEISCHNER 2017Incidental Pulmonary Nodule Management

Nodule Characteristics

*High risk includes heavy smokers or history of malignancy.

Awaiting Nodule Size

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

For incidental pulmonary nodules found on CT scans (e.g., a scan performed for abdominal pain or trauma).
Applicable to adults ≥ 35 years old.
NOT applicable to patients with a known primary cancer, immunosuppression, or those in a formal Lung Cancer Screening program (where Lung-RADS is used).

How it Works

Solid Nodule Management

Nodule SizeLow Risk PatientHigh Risk Patient
< 6 mmNo routine follow-up.Optional CT at 12 months.
6 - 8 mmCT at 6-12 months.CT at 6-12 months, then 18-24 months.
> 8 mmCT at 3 months, PET-CT, or biopsy.Same as low risk.

Clinical Pearls

Subsolid / Ground-Glass Nodules

Pure ground-glass nodules (GGN) < 6 mm require no follow-up. For those ≥ 6 mm, the guidelines recommend a follow-up at 6-12 months and then every 2 years for 5 years, as these lesions represent slow-growing indolent adenocarcinomas (AIS/MIA).

Risk Factors

High-risk patients include heavy smokers, those with a family history of lung cancer, or those with suspicious nodule morphology (e.g., spiculation). These patients require more aggressive longitudinal surveillance.

The Evidence

Key Reference

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Scans: From the Fleischner Society 2017

MacMahon H et al. • Radiology. 2017;284(1):228-243

Last Comprehensive Review: 2026

Related Tools

Lung-RADS v2022
TNM 9th Ed
NSCLC GPA
Oncology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.

Recent Journal Updates

JAMAJul 21, 2026
Earlier Egg Introduction Recommendations Linked to Fewer Infant Allergies

Clinical Context

We think this might be relevant to the clinical guidance for Fleischner Society 2017 Guidelines.

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this might be relevant to the clinical guidance for Fleischner Society 2017 Guidelines.

WHO NewsJul 15, 2026
New WHO guidelines: up to 45% of dementia risk could be prevented or delayed

Clinical Context

We think this might be relevant to the clinical guidance for Fleischner Society 2017 Guidelines.